Ventricular bigeminy is a cardiac anomaly marked by an irregular rhythm within the heart's ventricles, featuring a distinctive pattern characterized by a premature ventricular contraction (PVC) following each normal heartbeat. This arrhythmic condition introduces a unique cadence on electrocardiogram (ECG) recordings, showcasing an alternation between the regular beat and the premature contraction. The term "bigeminy" derives from the Latin word "gemini," signifying twins, symbolizing the pairing of every typical beat with a premature one. While individuals with ventricular bigeminy may not always experience overt symptoms, some may perceive palpitations, dizziness, or a fluttering sensation in the chest. Recognizing and diagnosing this cardiac irregularity is imperative for proper management and addressing potential underlying cardiovascular issues. Comprehensive medical evaluation, including ECG, holter monitor, or other specialized cardiac tests, is typically employed to assess the extent of ventricular bigeminy and formulate an appropriate course of action for optimal patient care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation